Ikeuchi H et al. |
Fluvastatin reduces renal fibroblast proliferation and production of type III collagen: therapeutic implications for tubulointerstitial fibrosis. |
2004 |
Nephron Exp. Nephrol. |
pmid:15331935
|
Eckert GP et al. |
Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. |
2009 |
Neurobiol. Dis. |
pmid:19464372
|
Tringali G et al. |
Lovastatin and mevastatin reduce basal and cytokine-stimulated production of prostaglandins from rat microglial cells in vitro: evidence for a mechanism unrelated to the inhibition of hydroxy-methyl-glutaryl CoA reductase. |
2004 |
Neurosci. Lett. |
pmid:14698450
|
Woo IS et al. |
Farnesyl diphosphate synthase attenuates paclitaxel-induced apoptotic cell death in human glioblastoma U87MG cells. |
2010 |
Neurosci. Lett. |
pmid:20298756
|
Mans RA et al. |
Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation. |
2012 |
Neuroscience |
pmid:22192838
|
Ghosh PM et al. |
Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line. |
1999 |
Oncogene |
pmid:10435593
|
Shaikenov TE et al. |
Arglabin-DMA, a plant derived sesquiterpene, inhibits farnesyltransferase. |
2001 Jan-Feb |
Oncol. Rep. |
pmid:11115593
|
Notarnicola M et al. |
Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis. |
2004 |
Oncology |
pmid:15713990
|
Sharon C et al. |
Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo. |
2015 |
Oncotarget |
pmid:25895029
|
van Klink J et al. |
Biosynthesis of anthecotuloide, an irregular sesquiterpene lactone from Anthemis cotula L. (Asteraceae) via a non-farnesyl diphosphate route. |
2003 |
Org. Biomol. Chem. |
pmid:12926279
|
Miller DJ et al. |
6- and 14-Fluoro farnesyl diphosphate: mechanistic probes for the reaction catalysed by aristolochene synthase. |
2009 |
Org. Biomol. Chem. |
pmid:19225680
|
Hong YJ and Tantillo DJ |
Modes of inactivation of trichodiene synthase by a cyclopropane-containing farnesyldiphosphate analog. |
2009 |
Org. Biomol. Chem. |
pmid:19763318
|
Miller DJ et al. |
Competitive inhibition of aristolochene synthase by phenyl-substituted farnesyl diphosphates: evidence of active site plasticity. |
2007 |
Org. Biomol. Chem. |
pmid:17912381
|
Rawat DS and Gibbs RA |
Synthesis of 7-substituted farnesyl diphosphate analogues. |
2002 |
Org. Lett. |
pmid:12201708
|
Shao Y et al. |
Stereospecific synthesis and biological evaluation of farnesyl diphosphate isomers. |
1999 |
Org. Lett. |
pmid:10823190
|
Rozema DB et al. |
Yeast protein farnesyltransferase. Binding of S-alkyl peptides and related analogues. |
1999 |
Org. Lett. |
pmid:10823210
|
Placzek AT et al. |
Synthesis of frame-shifted farnesyl diphosphate analogs. |
2012 |
Org. Lett. |
pmid:22857735
|
Placzek AT and Gibbs RA |
New synthetic methodology for the construction of 7-substituted farnesyl diphosphate analogs. |
2011 |
Org. Lett. |
pmid:21699139
|
Subramanian T et al. |
Directed library of anilinogeranyl analogues of farnesyl diphosphate via mixed solid- and solution-phase synthesis. |
2005 |
Org. Lett. |
pmid:15901146
|
Bang S et al. |
Isopentenyl pyrophosphate is a novel antinociceptive substance that inhibits TRPV3 and TRPA1 ion channels. |
2011 |
Pain |
pmid:21353389
|